Global Head CMC and Manufacturing Operations
Mr. Doorbar has extensive experience across all phases of drug and medical device development and manufacturing. This includes formulation and analytical development, process scale-up, product validation, technology transfer, quality control, manufacturing, materials management and product lifecycle oversight. With over 25 years’ experience he spent 10 years at Shire Pharmaceuticals where his responsibilities included CNS. At Mundipharma research he lead the development of drug device combination products within oncology and inhalation indications more recently he led new product development at Juniper Pharmaceuticals Inc. Mr. Doorbar has overseen successful filing and approvals for 11 commercial products (NDAs, MAAs) across the US, EU and Asia in addition to 30 successful INDs/IMPDs globally for phase I– IV clinical studies. Martin holds a BSc (Hons) in Applied/Analytical Chemistry a from Staffordshire University. He is a member of the Royal Society of Chemistry (M.R.S.C.).